STO · IBT-B.ST
Infant Bacterial Therapeutics AB (publ)
SEK 68.30+SEK 0.40 (+0.59%)
Infant Bacterial Therapeutics AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 19.55% below the high.
Loading market information…
STO · ADDV-B.ST · SEK
Stock price, dividends, earnings
Quote as of Feb 17, 2026, 04:29 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SEK. Historical prices are not a forecast.
ADDvise Group AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 34.84% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow ADDvise Group AB (publ)’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ADDvise Group AB (publ), established in Stockholm, Sweden, in 1989, furnishes specialized equipment to both public and private medical and scientific institutions globally, with operations spanning Sweden, the broader European continent, North America, Africa, and Asia. The company's business is structured into two primary divisions: Lab and Healthcare. The Lab segment is dedicated to the development, production, and distribution of controlled environment solutions and advanced ventilation systems specifically for laboratories. It also supplies precision weighing instruments for scientific, industrial, and retail applications, alongside a comprehensive range of laboratory instruments like centrifuges, water baths, and environmental chambers. This division further provides maintenance services for scales and lab apparatus, product storage solutions, and offers laboratory furniture and general equipment. Conversely, the Healthcare division specializes in the design, production, and commercialization of a wide array of medical devices. This includes surgical operating tables, general healthcare and safety goods, medical technology cables, connectivity solutions, orthopedic implants, specialized stents for foot and ankle procedures, and patient monitoring devices with associated software. This unit also distributes disposable medical supplies, ultrasound imaging systems, radiographic machinery, and specialized examination tables for urological and gynecological practices, in addition to managing an e-pharmacy platform.
Latest available per-share figures in SEK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| SEK 403.60M-3.47% vs estimate |
| Q2 2024 | Jul 18, 2024 | SEK 0.06+6.76% vs estimate | SEK 412.30M-0.45% vs estimate |
|---|
| Q1 2024 | Apr 18, 2024 | SEK 0.09+8.46% vs estimate | SEK 413.40M-5.3% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 68.30+SEK 0.40 (+0.59%)
Infant Bacterial Therapeutics AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 19.55% below the high.
SEK 9.22+SEK 0.23 (+2.56%)
Sedana Medical AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 33.76% below the high.
SEK 0.47-SEK 0.01 (-2.08%)
Doxa AB’s quoted price sits in the upper half of its reported 52-week range, 14.55% below the high.
SEK 31.50+SEK 0.90 (+2.94%)
FluoGuide A/S’s quoted price sits in the lower half of its reported 52-week range, 34.1% below the high.
SEK 3.20+SEK 0.40 (+14.08%)
Senzime AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 48.72% below the high.
SEK 16.00-SEK 0.10 (-0.62%)
Bactiguard Holding AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 25.93% below the high.
SEK 1.67+SEK 0.20 (+13.2%)
Cantargia AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 74.63% below the high.
SEK 15.50-SEK 0.50 (-3.13%)
Mentice AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 18.21% below the high.
